Lilly Sues Apotex Over Lung Cancer Drug Patent

Law360, New York (April 18, 2012, 12:19 PM EDT) -- Eli Lilly & Co. sued generic-drug maker Apotex Inc. on Tuesday in Indiana federal court over its alleged infringement of a patent on Eli Lilly's chemotherapy drug Alimta, used to treat several types of lung cancer.

Toronto-based Apotex has plans to create a generic version of Alimta, and included in its abbreviated new drug application with the U.S. Food and Drug Administration a method for administering the chemotherapy agent in combination with folic acid and vitamin B12, which would be detailed on the generic's labeling, the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.